Enhancement of the glucose metabolism and the reverse cholesterol transport by a peroxisome proliferator receptor ? (PPARa) agonist included in the fasciolosis treatment in naturally infested sheep

Basit Öğe Kaydı
dc.authorscopusid35618550600
dc.authorscopusid12243148200
dc.authorscopusid35603069000
dc.authorscopusid7004664599
dc.authorscopusid6602751642
dc.contributor.authorYüksek, N.
dc.contributor.authorAltu?, N.
dc.contributor.authorDenizhan, V.
dc.contributor.authorCeylan, E.
dc.contributor.authorA?ao?lu, Z.
dc.date.accessioned2024-09-19T15:43:45Z
dc.date.available2024-09-19T15:43:45Z
dc.date.issued2013
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractThe purpose of this study was to investigate the effects of PPAR? agonist on metabolic parameters in naturally Fasciola-infected sheep. Twenty sheep with fasciolosis were allotted in 2 equal groups according to the received treatment (triclabendazole/levamisole in the group I and triclabendazole/ levamisole + PPARa agonist (2-methyl-2-phenoxy-propionic acid) in the group II) and the haematological and biochemical parameters were assessed before the treatment and 7, 14 and 28 days after and were compared to control values determined from 10 healthy sheep. As expected, fasciolosis has induced an anaemia evidenced by low haematocrit and low haemoglobinemia coupled to eosinophilia and to a moderate lymphopenia, severe liver damage characterised by hepatocyte degenerescence (significant increases in serum AST and GDH activities) and bile duct obstruction (significant increases in serum GGT activity and in serum bile acid concentrations) leading to impairement in liver metabolic functions (hypoalbuminemia, marked decreases in serum glucose concentrations and in LDL associated cholesterol concentrations). All the heamatological and biochemical alterations were at least partially alleviated by the antihelminthic treatment except the serum triglyceride concentrations which have continued to decrease during the post-treatment period and the total cholesterol and HDL associated cholesterol concentrations which have markedly increased, particularly when sheep were also treated with the PPARa agonist. These results clearly demonstrated the severe metabolic liver impairment occurring during fasciolosis in sheep and the beneficial effects of the PPARa agonist on the correction of the negative energy balance, particularly by promoting the reverse cholesterol transport.en_US
dc.identifier.endpage172en_US
dc.identifier.issn0035-1555
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-84875757676en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage163en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/14542
dc.identifier.volume164en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.relation.ispartofRevue de Medecine Veterinaireen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBiochemical analysisen_US
dc.subjectCholesterolen_US
dc.subjectFasciolosisen_US
dc.subjectGlucoseen_US
dc.subjectHaematological analysisen_US
dc.subjectLipid profilesen_US
dc.subjectLipoproteinsen_US
dc.subjectLiveren_US
dc.subjectPPAR? agonisten_US
dc.subjectSheepen_US
dc.titleEnhancement of the glucose metabolism and the reverse cholesterol transport by a peroxisome proliferator receptor ? (PPARa) agonist included in the fasciolosis treatment in naturally infested sheepen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu